Search Results

Continued Recognition Award for CSI (Compliance Services International)

The Pentlands Science Park company CSI (Compliance Services International) is once again proud to have received a highly commended award at in the Best Supporting Role category at the 2014 AGROW Awards ceremony.

Engineering Apprentice for Pentlands Science Park

Pentlands Science Park announce a new recruit under the Modern Apprenticeship Scheme.

International science parks forum

Pentlands Science Park was one of the parks from the UK which was represented at the recent IASP2014, the 31st world conference of International Association of Science Parks and Areas of Innovation.

The Princess Royal visits Moredun

HRH The Princess Royal visits Moredun Foundation to find out how creative design has been applied to benefit the health and welfare of livestock.

Moredun’s Director of Communications wins prestigious Scottish Knowledge Exchange Award

Congratulations to Professor Lee Innes, Moredun’s Director of Communications, who received an award for Outstanding Contribution to Knowledge Exchange at the prestigious Scottish Knowledge Exchange Awards.

Launch of new poultry laboratory

Biobest Laboratories announce the launch of their poultry laboratory, a new state of the art facility located on Pentlands Science Park.

Royal Smithfield Club Bicentenary Trophy congratulations

Professor Julie Fitzpatrick is awarded the Royal Smithfield Club Bicentenary Trophy by HRH The Princess Royal on a visit to Moredun.

Biotangents locates at Pentlands Science Park

Pentlands Science Park is delighted to welcome Biotangents as its latest tenant.

Scottish immunotherapy company secures over £6m in funding

TC BioPharm has secured more than £6.25 million to press ahead with the development of innovative cancer treatments.

Mike Leek of TC Biopharm wins Entrepreneurial Business Leadership Award

The annual Scottish Life Science Awards recognise the success and achievements of Scotland’s internationally-renowned life sciences sector.

TC Biopharm gets €4m Horizon2020 grant

TC BioPharm has been selected for EU Horizon 2020 Funding to progress novel, mass-market cell therapies to clinical trial.

The Princess Royal attends a special event to celebrate Moredun's unique partnership with the farming industry

Her Royal Highness, The Princess Royal attended a special event held at Pentlands Science Park to celebrate Moredun’s rich heritage and unique partnership with the farming industry.

TC BioPharm and the NIPRO Corporation announce strategic programme co-developing a novel gamma-delta CAR-T product to treat cancer

TC BioPharma, the Scottish biotechnology firm, has teamed up with Japanese pharmaceutical company, NIPRO Corporation, to develop a new type of cancer therapy.

TC BioPharm wins Life Sciences Company of the Year 2018

TC BioPharm won the "Life Science Company of the Year" last night at the Business Insider Made in Scotland Awards 2018.

TC BioPharm broadens CAR-T drug pipeline

TC BioPharm Ltd (TCB) and Scotia Biologics announce a strategic collaboration to co-develop novel proprietary tumour-specific antibodies for TCB’s CAR-T platform.

Well Cow is Moo-ving

Well Cow, developers of nutrition management technology to improve the health and welfare of cows, has relocated to Pentlands Science Park.

TC BioPharm partners with Trinity College Dublin to develop V delta 1 γδ T cell-based cancer treatments

Immunotherapy company TC BioPharm partners with Trinity College Dublin to develop V delta 1 γδ T cell-based cancer treatments with clinical programme scheduled to commence late 2019.

TC BioPharm creates allogeneic cell banks for CAR-T cancer therapy products

The first completed bio-banks will be used to develop more cost-effective, safe and efficacious cancer treatments.

TC BioPharm starts clinical study in cancer patients

Oncology centres in Glasgow and Edinburgh commence recruitment of skin, lung and kidney cancer patients.

TC BioPharm announce strategic collaboration with bluebird bio to develop gamma delta T Cell capabilities

bluebird bio and Scottish immunotherapy company TC BioPharm announce a strategic collaboration and license agreement focused on gamma delta CAR-T cells for cancer immunotherapy.

Gates Foundation announce new $40 million investment in GALVmed to boost British livestock research for world’s poorest people

The Gates Foundation announce an additional $40 million over five years for the Global Alliance for Livestock Veterinary Medicines (GALVmed), a public-private partnership which develops livestock vaccines, medicines and diagnostics.